๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Determination of serum soluble macrophage colony-stimulating factor receptor levels in patients with hematological diseases

โœ Scribed by Qing Rao; Jing-shu Han; Xiao-jin Sha; Ren-chi Yang; Guo-guang Zheng; Ke-fu Wu


Publisher
Chinese Anti-Cancer Association
Year
2001
Tongue
English
Weight
467 KB
Volume
13
Category
Article
ISSN
1000-9604

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Multicentric Castleman's disease with an
โœ Lee, Muneyasu; Hirokawa, Makoto; Matuoka, Satoru; Hasegawa, Hitoshi; Nanjo, Hiro ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 32 KB ๐Ÿ‘ 1 views

We describe a 74-year-old patient with multicentric Castleman's disease (MCD) whose serum macrophage colony-stimulating factor level was elevated. Serum levels of tumor necrosis factor-โฃ and interleukin 6 were also elevated at presentation, and they returned to normal levels after chemotherapy. Alth

Increased levels of soluble complement r
โœ S Sadallah; E Giostra; G Mentha; J A Schifferli ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB

with leukemia have high serum levels of sCR1 may indicate Complement receptor type 1 (CR1) is an integral memhigh synthetic and shedding rates of this receptor. 7 brane protein of many hematopoietic cells and is found In a preliminary study on a small group of patients with in a soluble form in pla